| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.97B | 81.45B | 84.41B | 82.11B | 83.86B | 80.14B |
| Gross Profit | 20.62B | 20.70B | 20.17B | 16.73B | 18.34B | 21.05B |
| EBITDA | 10.08B | 10.19B | 9.85B | 7.42B | 8.96B | 11.96B |
| Net Income | 4.87B | 2.75B | 5.01B | -7.09B | 2.34B | 6.75B |
Balance Sheet | ||||||
| Total Assets | 123.36B | 117.22B | 123.32B | 125.44B | 128.02B | 123.92B |
| Cash, Cash Equivalents and Short-Term Investments | 16.39B | 15.50B | 16.42B | 16.71B | 12.41B | 10.88B |
| Total Debt | 22.98B | 16.00B | 21.92B | 27.04B | 21.64B | 16.96B |
| Total Liabilities | 45.67B | 38.29B | 43.93B | 49.98B | 43.30B | 41.21B |
| Stockholders Equity | 76.64B | 77.71B | 78.29B | 74.39B | 80.49B | 78.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.41B | 5.06B | 2.84B | -1.89B | 1.50B |
| Operating Cash Flow | 0.00 | 14.48B | 12.01B | 6.87B | 773.00M | 6.57B |
| Investing Cash Flow | 0.00 | -4.64B | -5.71B | -3.96B | -2.62B | -1.65B |
| Financing Cash Flow | 0.00 | -10.59B | -6.88B | 1.26B | 3.28B | -5.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥125.61B | 16.30 | 15.07% | 1.74% | 7.82% | 64.90% | |
76 Outperform | ¥91.66B | 28.34 | 6.31% | 4.01% | 1.41% | 7.59% | |
70 Outperform | ¥85.08B | 11.29 | ― | 3.74% | 0.53% | 30.98% | |
69 Neutral | ¥54.49B | 12.13 | ― | 2.92% | -5.24% | 17.53% | |
65 Neutral | ¥62.94B | 27.94 | ― | 4.37% | -3.84% | -43.55% | |
62 Neutral | ¥25.19B | 10.86 | ― | 4.62% | 2.73% | 206.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |